Ronald H. Blum

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

J M Kirkwood, M H Strawderman, Marc S. Ernstoff et al. · Journal of Clinical Oncology · 1996 · 2.1K citations

Medicine, Oncology, Pharmacotherapy +17

Pain and Its Treatment in Outpatients with Metastatic Cancer

Charles S. Cleeland, René Gonin, Alan K. Hatfield et al. · New England Journal of Medicine · 1994 · 2K citations

Medicine, Oncology, Cancer Pain Management +7

Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

Andrew T. Turrisi, KyungMann Kim, Ronald H. Blum et al. · New England Journal of Medicine · 1999 · 1.5K citations · Full text

Medicine, Oncology, Radiation Oncology +11

High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190

John M. Kirkwood, Joseph G. Ibrahim, Vernon K. Sondak et al. · Journal of Clinical Oncology · 2000 · 922 citations

Pharmacy, Oncology, Pharmacotherapy +15

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

J H Edmonson, Louise Ryan, Ronald H. Blum et al. · Journal of Clinical Oncology · 1993 · 518 citations

Medicine, Oncology, Cancer Pharmacology +13